Invesco Ltd. Bausch Health Companies Inc. Transaction History

Invesco Ltd.

$460 Billion
Q2 2024

A detailed history of Invesco Ltd. transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Invesco Ltd. holds 156,302 shares of BHC stock, worth $1.29 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

156,302

Previous 159,385 1.93%

Holding current value

$1.29 Million

Previous $1.69 Million 35.6%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$6.1 - $10.41 $18,806 - $32,094	-3,083 Reduced 1.93%	156,302 $1.09 Million
Q1 2024 May 14, 2024	SELL	$7.77 - $10.61 $9.31 Million - $12.7 Million	-1,197,871 Reduced 88.26%	159,385 $1.69 Million
Q4 2023 Feb 12, 2024	SELL	$6.53 - $8.23 $33,218 - $41,866	-5,087 Reduced 0.37%	1,357,256 $10.9 Million
Q3 2023 Nov 13, 2023	SELL	$7.69 - $9.71 $1.2 Million - $1.52 Million	-156,648 Reduced 10.31%	1,362,343 $11.2 Million
Q2 2023 Aug 11, 2023	BUY	$5.72 - $8.8 $757,390 - $1.17 Million	132,411 Added 9.55%	1,518,991 $12.2 Million
Q1 2023 May 12, 2023	BUY	$6.28 - $9.85 $1.06 Million - $1.67 Million	169,204 Added 13.9%	1,386,580 $11.2 Million
Q4 2022 Feb 13, 2023	SELL	$6.09 - $7.93 $6.1 Million - $7.95 Million	-1,002,395 Reduced 45.16%	1,217,376 $7.65 Million
Q3 2022 Nov 14, 2022	BUY	$4.58 - $9.21 $4.33 Million - $8.7 Million	944,835 Added 74.11%	2,219,771 $15.3 Million
Q2 2022 Aug 15, 2022	BUY	$7.06 - $23.63 $4.86 Million - $16.3 Million	688,477 Added 117.4%	1,274,936 $10.7 Million
Q1 2022 May 16, 2022	SELL	$21.6 - $27.79 $2 Million - $2.57 Million	-92,385 Reduced 13.61%	586,459 $13.4 Million
Q4 2021 Feb 14, 2022	SELL	$23.0 - $29.01 $1.26 Million - $1.6 Million	-54,989 Reduced 7.49%	678,844 $18.7 Million
Q3 2021 Nov 15, 2021	BUY	$25.04 - $30.06 $5.53 Million - $6.64 Million	221,043 Added 43.11%	733,833 $20.4 Million
Q2 2021 Aug 17, 2021	BUY	$27.43 - $32.7 $1.78 Million - $2.12 Million	64,798 Added 14.46%	512,790 $15 Million
Q1 2021 May 17, 2021	SELL	$21.37 - $34.38 $4 Million - $6.44 Million	-187,307 Reduced 29.48%	447,992 $14.2 Million
Q4 2020 Feb 16, 2021	SELL	$15.31 - $21.12 $828,791 - $1.14 Million	-54,134 Reduced 7.85%	635,299 $13.2 Million
Q3 2020 Nov 16, 2020	BUY	$14.88 - $20.13 $563,088 - $761,759	37,842 Added 5.81%	689,433 $10.7 Million
Q2 2020 Aug 14, 2020	BUY	$13.31 - $20.51 $1.38 Million - $2.13 Million	103,768 Added 18.94%	651,591 $11.9 Million
Q1 2020 May 15, 2020	SELL	$12.98 - $30.25 $2.62 Million - $6.11 Million	-202,032 Reduced 26.94%	547,823 $8.49 Million
Q4 2019 Feb 14, 2020	BUY	$18.89 - $31.89 $2.76 Million - $4.65 Million	145,872 Added 24.15%	749,855 $22.4 Million
Q3 2019 Nov 14, 2019	SELL	$20.88 - $25.66 $1.58 Million - $1.94 Million	-75,435 Reduced 11.1%	603,983 $13.2 Million
Q2 2019 Aug 14, 2019	SELL	$20.52 - $26.45 $628,548 - $810,189	-30,631 Reduced 4.31%	679,418 $17.1 Million
Q1 2019 May 15, 2019	SELL	$20.23 - $26.29 $1.72 Million - $2.24 Million	-85,074 Reduced 10.7%	710,049 $17.5 Million
Q4 2018 Feb 14, 2019	BUY	$17.64 - $28.32 $14 Million - $22.5 Million	795,123 New	795,123 $14.7 Million

Others Institutions Holding BHC

# of Institutions

275

Shares Held

279M

Call Options Held

5.68M

Put Options Held

17.4M

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.99B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account